// <auto-generated/>
// Contents of: hl7.fhir.r4.core version: 4.0.1
  // Primitive Naming Style: None
  // Complex Type / Resource Naming Style: PascalCase
  // Interaction Naming Style: None
  // Extension Support: NonPrimitive
// Minimum TypeScript Version: 3.7
import { Coding } from '../models'
/**
 * Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.
 */
export const ResearchStudyPhase = {
  /**
   * Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
   */
  research_study_phase_EarlyPhase1: {
    code: "early-phase-1",
    display: "Early Phase 1",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Trials without phases (for example, studies of devices or behavioral interventions).
   */
  research_study_phase_NA: {
    code: "n-a",
    display: "N/A",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
   */
  research_study_phase_Phase1: {
    code: "phase-1",
    display: "Phase 1",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Trials that are a combination of phases 1 and 2.
   */
  research_study_phase_Phase1Phase2: {
    code: "phase-1-phase-2",
    display: "Phase 1/Phase 2",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
   */
  research_study_phase_Phase2: {
    code: "phase-2",
    display: "Phase 2",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Trials that are a combination of phases 2 and 3.
   */
  research_study_phase_Phase2Phase3: {
    code: "phase-2-phase-3",
    display: "Phase 2/Phase 3",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
   */
  research_study_phase_Phase3: {
    code: "phase-3",
    display: "Phase 3",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
  /**
   * Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
   */
  research_study_phase_Phase4: {
    code: "phase-4",
    display: "Phase 4",
    system: "http://terminology.hl7.org/CodeSystem/research-study-phase"
  } as Coding,
};
